Your browser doesn't support javascript.
loading
Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.
Balaji, Seshadri; DiLorenzo, Michael P; Fish, Frank A; Etheridge, Susan P; Aziz, Peter F; Russell, Mark W; Tisma, Svjetlana; Pflaumer, Andreas; Sreeram, Narayanswami; Kubus, Peter; Law, Ian H; Kantoch, Michal J; Kertesz, Naomi J; Strieper, Margaret; Erickson, Christopher C; Moore, Jeremy P; Nakano, Stephanie J; Singh, Harinder R; Chang, Philip; Cohen, Mitchell; Fournier, Anne; Ilina, Maria V; Smith, Richard T; Zimmerman, Frank; Horndasch, Michaela; Li, Walter; Batra, Anjan; Liberman, Leonardo; Hamilton, Robert; Janson, Christopher M; Sanatani, Shubhayan; Zeltser, Ilana; McDaniel, George; Blaufox, Andrew D; Garnreiter, Jason M; Katcoff, Hannah; Shah, Maully.
Afiliação
  • Balaji S; Oregon Health & Science University, Portland, Oregon. Electronic address: balajis@ohsu.edu.
  • DiLorenzo MP; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Fish FA; Vanderbilt University, Nashville, Tennessee.
  • Etheridge SP; University of Utah, Salt Lake City, Utah.
  • Aziz PF; Cleveland Clinic, Cleveland, Ohio.
  • Russell MW; C.S. Mott Children's Hospital, Ann Arbor, Michigan.
  • Tisma S; Mercy Children's Hospital, Kansas City, Missouri.
  • Pflaumer A; Royal Children's Hospital, Melbourne, Australia.
  • Sreeram N; University of Cologne, Cologne, Germany.
  • Kubus P; Motol University, Prague, Czech Republic.
  • Law IH; University of Iowa, Iowa City, Iowa.
  • Kantoch MJ; University of Alberta, Edmonton, Alberta, Canada.
  • Kertesz NJ; Nationwide Children's Hospital, Columbus, Ohio.
  • Strieper M; Sibley Heart Center, Atlanta, Georgia.
  • Erickson CC; Children's Hospital, Omaha, Nebraska.
  • Moore JP; University of California, Los Angeles, Los Angeles, California.
  • Nakano SJ; University of Colorado, Denver, Colorado.
  • Singh HR; Children's Hospital of Michigan, Detroit, Michigan.
  • Chang P; Children's Hospital of Los Angeles, Los Angeles, California.
  • Cohen M; Phoenix Children's Hospital, Phoenix, Arizona.
  • Fournier A; University of Montreal, Montreal, Quebec, Canada.
  • Ilina MV; Royal Children's Hospital, Glasgow, Scotland, United Kingdom.
  • Smith RT; Carolinas Health System, Charlotte, North Carolina.
  • Zimmerman F; Advocate Hospital, Chicago, Illinois.
  • Horndasch M; German Heart Center, Munich, Germany.
  • Li W; University of California, San Francisco, San Francisco, California.
  • Batra A; University of California, Irvine, Irvine, California.
  • Liberman L; Columbia University, New York, New York.
  • Hamilton R; Hospital for Sick Kids, Toronto, Ontario, Canada.
  • Janson CM; Montefiore Hospital, New York, New York.
  • Sanatani S; University of British Columbia, Vancouver, British Columbia, Canada.
  • Zeltser I; University of Texas-Southwestern, Dallas, Texas.
  • McDaniel G; University of Virginia, Charlottesville, Virginia.
  • Blaufox AD; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
  • Garnreiter JM; Saint Louis University, Saint Louis, Missouri.
  • Katcoff H; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Shah M; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Heart Rhythm ; 16(10): 1462-1467, 2019 10.
Article em En | MEDLINE | ID: mdl-31026510
ABSTRACT

BACKGROUND:

Predictors of risk of lethal arrhythmic events (LAE) is poorly understood and may differ from adults in children with hypertrophic cardiomyopathy (HCM).

OBJECTIVE:

The purpose of this study was to determine predictors of LAE in children with HCM.

METHODS:

A retrospective data collection was performed on 446 children and teenagers 20 years and younger (290 [65%] male; mean age 10.1 ± 5.7 years) with idiopathic HCM from 35 centers. Patients were classified as group 1 (HCM with LAE) if having a secondary prevention implantable cardioverter-defibrillator (ICD) or primary prevention ICD with appropriate interventions or group 2 (HCM without LAE) if having a primary prevention ICD without appropriate interventions.

RESULTS:

There were 152 children (34%) in group 1 and 294 (66%) in group 2. Risk factors for group 1 by univariate analysis were septal thickness, posterior left ventricular (LV) wall thickness, lower LV outflow gradient, and Q wave > 3 mm in inferior electrocardiographic leads. Factors not associated with LAE were family history of SCD, abnormal blood pressure response to exercise, and ventricular tachycardia on ambulatory electrocardiographic monitoring. Risk factors for SCD by multivariate analysis were age at ICD placement (hazard ratio [HR] 0.9; P = .0025), LV posterior wall thickness z score (HR 1.02; P < .005), and LV outflow gradient < 30 mm Hg (HR 2.0; P < .006). LV posterior wall thickness z score ≥ 5 was associated with LAE.

CONCLUSION:

Risk factors for LAE appear different in children compared to adults. Conventional adult risk factors were not significant in children. Further prospective studies are needed to improve risk stratification for LAE in children with HCM.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Cardiomiopatia Hipertrófica / Morte Súbita Cardíaca / Desfibriladores Implantáveis Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Cardiomiopatia Hipertrófica / Morte Súbita Cardíaca / Desfibriladores Implantáveis Idioma: En Ano de publicação: 2019 Tipo de documento: Article